Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
ResMed Inc. Chess Depositary Interest represents equity ownership in ResMed Inc., a global leader in digital health and medical devices, specifically targeting respiratory care and sleep disorders. Issued as Chess Depositary Interests (CDIs) in Australia, each unit typically corresponds to an underlying share in the U.S.-based parent company, facilitating local investor access to ResMed's international operations. The primary function of ResMed Inc. is the development and distribution of cloud-connected medical devices and supporting software-as-a-service platforms aimed at transforming care for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic health conditions. The business operates predominantly in the healthcare sector, with a core focus on medical instruments, supplies, and health technology innovation. ResMed holds a prominent position within the global market for respiratory care, benefiting from strong margins and returns on equity, and is considered a major competitor alongside firms like Philips and Fisher & Paykel Healthcare. Through the CDI structure, ResMed allows Australian investors to participate in the growth and performance of a significant international healthcare company, supporting both clinical outcomes and digital transformation within the medical sector.